ENTITY

Dyadic International (DYAI US)

15
Analysis
Health Care • United States
Dyadic International, Inc. is a global biotechnology company. The Company focuses on improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market. Dyadic International focuses on drugs that will improve access and cost to patients as well as save lives.
more
bullish•Dyadic International
•08 Aug 2026 22:32

Primer: Dyadic International (DYAI US) - Aug 2026

Dyadic International is a biotechnology company centered on its proprietary C1 and Dapibus™ microbial expression platforms, designed for...

Share
x